Update: GDPR compliance - Klebo/eventflo Conferences

Martin Swarbrick

 Martin Swarbrick
Martin Swarbrick
Director R&D Chemistry
Ryvu Therapeutics
Speaker

Presentations at Update: GDPR compliance - Klebo/eventflo Conferences

Profile of Martin Swarbrick

Martin obtained a BSc and PhD in chemistry from the University of Sheffield, UK, and carried out post-doctoral research at the University of Montreal, Canada. He returned to the UK to take up a role in industrial drug discovery and development at GlaxoSmithKline, where he went on to lead medicinal chemistry teams and discovery projects. In 2008, Martin joined CRUK’s Therapeutic Discovery Laboratories (CRUK-TDL) where, until recently, he led the medicinal chemistry, DMPK, protein sciences and structural biology functions. In June 2021 Martin joined Ryvu Therapeutics as Director of R&D Chemistry.

Email

Please login to send a Private Message

Hosted By

Klebo (Eventflo) Conference Platform

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'